BioRankings LLC is a biostatistical consulting service providing statistical due diligence to identify strengths and weaknesses of statistical data that may impact a biotech firm’s long term viability. Founded by Dr. William Shannon, Associate Professor of Biostatistics in Medicine at the Washington University School of Medicine in St. Louis, BioRankings LLC brings over 20 years of applied biostatistical expertise in biomedical, pharmaceutical, and biotech research. In addition to over 80 peer-reviewed publications in diverse areas such as oncology, pediatrics, genetics, cardiology, pulmonology, infectious disease, sleep medicine, health care delivery, and many other areas, BioRankings LLC staff have advanced technical expertise in biotechnology, genetics, cell and molecular biology, and technical writing. Our combined expertise allows us to make complex biostatistical ideas understandable.
Biostatistics, Statistical Due Diligence, Independent Statistical Analysis, Phase I/II/III Clinical Trials, Experimental Design
Study Groups are clusters of experts with similar progessional backgrounds, indsutry expertise, experience level, job function, geography, and other characteristics. These are the top Study Groups members of BioRankings, LLC belong to.
| Study Group Name | No. Members |
|---|---|
| Biostatisticians | 358 |
| Biostatisticians (US) | 254 |
GLG News analyses are expert commentaries on industry news and events. Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.
The data and news behind the FDA decison
January 31, 2010
William Shannon, Founder and President, BioRankings, LLC
Cancer Immunotherapy Explained
January 31, 2010
William Shannon, Founder and President, BioRankings, LLC
Meta-analysis of probiotics in atopic dermatitis
April 16, 2009
William Shannon, Founder and President, BioRankings, LLC
New FDA effort takes aim at genomics: Inherent risk to investors
February 6, 2009
William Shannon, Founder and President, BioRankings, LLC
Eli Lilly's Personal Medicine Goal
November 27, 2008
William Shannon, Founder and President, BioRankings, LLC